Micron to expand US investments to about $200 billion-March 2024-www.financetom.com

Micron to expand US investments to about $200 billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Micron to expand US investments to about $200 billion

Jun 12, 2025 5:50 AM

June 12 (Reuters) - Chipmaker Micron Technology said on

Thursday that it was planning to expand its U.S. investments in

domestic memory manufacturing to about $150 billion and in R&D

to $50 billion.

(Reporting by Arsheeya Bajwa in Bengaluru; Editing by Anil

D'Silva)

Previous page： Strathcona Resources Boosts Offer to Acquire MEG Energy Next page： Pfizer, partner BioNTech says updated COVID shot shows better immune response

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Strathcona Resources Boosts Offer to Acquire MEG Energy

Sep 8, 2025

06:47 AM EDT, 09/08/2025 (MT Newswires) -- Strathcona Resources ( STHRF ) on Monday increased its offer to acquire all of MEG Energy's ( MEGEF ) common shares it does not already own for 0.80 of a Strathcona common share per MEG share. Its previous offer was for 0.62 of a Strathcona share and $4.10 in cash per MEG share....

Pfizer, partner BioNTech says updated COVID shot shows better immune response

Sep 8, 2025

Sept 8 (Reuters) - Pfizer ( PFE ) and partner BioNTech said on Monday their updated COVID-19 vaccine showed an increased immune response in adults aged 65 and older as well as those aged 18 through 64 with at least one underlying risk condition. ...

Cybersecurity firm Netskope aims to raise up to $813 million in US IPO

Sep 8, 2025

Sept 8 (Reuters) - Netskope is aiming to raise as much as $812.6 million in an initial public offering in the United States, the cloud-based cybersecurity firm said on Monday. ...

Lilly's blood cancer drug meets main goal in late-stage study

Sep 8, 2025

Sept 8 (Reuters) - Eli Lilly ( LLY ) said on Monday its blood cancer treatment Jaypirca met the main goal in a late-stage study in patients who have not received prior treatment. (Reporting by Mariam Sunny in Bengaluru) ...